Breast cancer-related arm lymphoedema: a critical unmet need

Sandra C. Hayes; Michael Bernas; Melanie L. Plinsinga; Christopher Pyke; Christobel Saunders; Neil Piller; Christine Moffatt; Vaughan Keeley; Natalie Kruger; Hildegard Reul-Hirche; Alexandra L. McCarthy

doi:10.1016/j.eclinm.2024.102762

Breast cancer-related arm lymphoedema: a critical unmet need

Sandra C. Hayes, Michael Bernas, Melanie L. Plinsinga, Christopher Pyke, Christobel Saunders, Neil Piller, Christine Moffatt, Vaughan Keeley, Natalie Kruger, Hildegard Reul-Hirche, Alexandra L. McCarthy

College of Medicine and Public Health

Research output: Contribution to journal › Letter › peer-review

7 Downloads (Pure)

Abstract

One in five women treated for breast cancer develop breast cancer-related lymphoedema (BCRL), with subsequent profound impact on individuals and the healthcare system. Further, there is no known cure for lymphoedema, and it is costly to manage, imposing inequitable financial burdens. Contemporary management seeks to reduce impact and prevent progression. Unfortunately, advancement in lymphoedema care has been constrained by a lack of investment in lymphoedema services, underpinned by a limited research base, misunderstanding of lymphoedema prevalence and failure to recognise its associated morbidity. We appreciate the focus by the recently published MASCC clinical practice guidance for the prevention of BCRL as a critical unmet need...

Original language	English
Article number	102762
Number of pages	2
Journal	EClinicalMedicine
Volume	75
Early online date	26 Jul 2024
DOIs	https://doi.org/10.1016/j.eclinm.2024.102762
Publication status	Published - Sept 2024

Keywords

lymphoedema
cancer-related lymphoedema
breast cancer

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.eclinm.2024.102762Licence: CC BY-NC-ND

Final published versionFinal published version, 159 KBLicence: CC BY-NC-ND

Cite this

@article{e759af33fcce4b91bd5eac17079b98b8,

title = "Breast cancer-related arm lymphoedema: a critical unmet need",

abstract = "One in five women treated for breast cancer develop breast cancer-related lymphoedema (BCRL), with subsequent profound impact on individuals and the healthcare system. Further, there is no known cure for lymphoedema, and it is costly to manage, imposing inequitable financial burdens. Contemporary management seeks to reduce impact and prevent progression. Unfortunately, advancement in lymphoedema care has been constrained by a lack of investment in lymphoedema services, underpinned by a limited research base, misunderstanding of lymphoedema prevalence and failure to recognise its associated morbidity. We appreciate the focus by the recently published MASCC clinical practice guidance for the prevention of BCRL as a critical unmet need...",

keywords = "lymphoedema, cancer-related lymphoedema, breast cancer",

author = "Hayes, {Sandra C.} and Michael Bernas and Plinsinga, {Melanie L.} and Christopher Pyke and Christobel Saunders and Neil Piller and Christine Moffatt and Vaughan Keeley and Natalie Kruger and Hildegard Reul-Hirche and McCarthy, {Alexandra L.}",

year = "2024",

month = sep,

doi = "10.1016/j.eclinm.2024.102762",

language = "English",

volume = "75",

journal = "EClinicalMedicine",

issn = "2589-5370",

publisher = "Elsevier",

}

TY - JOUR

T1 - Breast cancer-related arm lymphoedema

T2 - a critical unmet need

AU - Hayes, Sandra C.

AU - Bernas, Michael

AU - Plinsinga, Melanie L.

AU - Pyke, Christopher

AU - Saunders, Christobel

AU - Piller, Neil

AU - Moffatt, Christine

AU - Keeley, Vaughan

AU - Kruger, Natalie

AU - Reul-Hirche, Hildegard

AU - McCarthy, Alexandra L.

PY - 2024/9

Y1 - 2024/9

N2 - One in five women treated for breast cancer develop breast cancer-related lymphoedema (BCRL), with subsequent profound impact on individuals and the healthcare system. Further, there is no known cure for lymphoedema, and it is costly to manage, imposing inequitable financial burdens. Contemporary management seeks to reduce impact and prevent progression. Unfortunately, advancement in lymphoedema care has been constrained by a lack of investment in lymphoedema services, underpinned by a limited research base, misunderstanding of lymphoedema prevalence and failure to recognise its associated morbidity. We appreciate the focus by the recently published MASCC clinical practice guidance for the prevention of BCRL as a critical unmet need...

AB - One in five women treated for breast cancer develop breast cancer-related lymphoedema (BCRL), with subsequent profound impact on individuals and the healthcare system. Further, there is no known cure for lymphoedema, and it is costly to manage, imposing inequitable financial burdens. Contemporary management seeks to reduce impact and prevent progression. Unfortunately, advancement in lymphoedema care has been constrained by a lack of investment in lymphoedema services, underpinned by a limited research base, misunderstanding of lymphoedema prevalence and failure to recognise its associated morbidity. We appreciate the focus by the recently published MASCC clinical practice guidance for the prevention of BCRL as a critical unmet need...

KW - lymphoedema

KW - cancer-related lymphoedema

KW - breast cancer

UR - http://www.scopus.com/inward/record.url?scp=85199433608&partnerID=8YFLogxK

U2 - 10.1016/j.eclinm.2024.102762

DO - 10.1016/j.eclinm.2024.102762

M3 - Letter

AN - SCOPUS:85199433608

SN - 2589-5370

VL - 75

JO - EClinicalMedicine

JF - EClinicalMedicine

M1 - 102762

ER -

Breast cancer-related arm lymphoedema: a critical unmet need

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this